Trial FAQs
Who can participate?
People aged 16 and above diagnosed with hidradenitis suppurativa (HS) may participate.
How long will the study last?
Around 67 weeks
What are the benefits?
- No cost to participate or receive study treatment
- Regular visits with study doctors who specialize in treating HS (20 study visits)
- Will receive either an investigative injection or a placebo
What is the inclusion criteria?
- A clinical diagnosis of moderate to severe HS for at least 6 months
- Have the presence of HS lesions in at least 2 distinct anatomic areas
- Intolerance to oral antibiotics for HS treatment
Clinical Trial for Hidradenitis Suppurativa
Patient Treatment Innovations
Clinical research trials serve as the avenue to allow these treatments and medications to eventually reach the public. Clinical trials involve human volunteer patients, allowing them to receive investigational treatments- a new drug or device. Trials are closely monitored by specialized physicians and are the primary way researchers can evaluate safety, efficacy, benefits and effectiveness of new treatments.
Dr. Yadav is proud to be at the forefront of dermatological research. In partnership with Probity Medical Research, one of the most highly regarded and renowned clinical research organizations across Canada and the United States, Dr. Yadav can offer patients the opportunity to participate in trials that have the newest and most advanced investigational treatments in dermatology.